Myriad Genetics reported $48M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Accelerate Diagnostics AXDX:US 2.16M 5K
Agilent A:US $ 746M 18M
Becton, Dickinson and BDX:US $ 2706M 134M
Bio Rad Laboratories BIO:US $ 296.5M 35.37M
Biocept BIOC:US $ 10.34M 0.3M
Bruker BRKR:US $ 288.7M 53.2M
Danaher DHR:US $ 2983M 222M
Exact Sciences EXAS:US $ 134.71M 15.65M
Fluidigm FLDM:US $ 14.27M 3.76M
Hologic HOLX:US $ 489.1M 4.3M
Illumina ILMN:US $ 408M 26M
Johnson & Johnson JNJ:US $ 7598M 357M
Mettler Toledo International MTD:US 378.21M 51.9M
Myriad Genetics MYGN:US $ 48M 2.2M
Nanostring Technologies NSTG:US $ 14.78M 5.27M
Orasure Technologies OSUR:US $ 43.44M 7M
Pacific Biosciences Of California PACB:US $ 19.02M 0.24M
Perkinelmer PKI:US $ 580.21M 34.99M
Quest Diagnostics DGX:US $ 1643M 36M
Quidel QDEL:US $ 262.3M 114.78M
Repligen RGEN:US $ 82.36M 0.31M
Thermo Fisher Scientific TMO:US $ 6354M 906M
Veracyte VCYT:US $ 23.71M 0.83M
Waters WAT:US $ 285.68M 65.32M